Literature DB >> 31820666

Acute Phase Proteins as Predictors of Survival in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease Requiring Mechanical Ventilation.

Arora Sneh1, Tiwari Pawan1, Guleria Randeep1, Mohan Anant1, Kalaivani Mani2, Vijay Hadda1, Karan Madan1.   

Abstract

Few studies have tried to assess prognostic variables in chronic obstructive pulmonary disease (COPD) patients requiring mechanical ventilation (MV). We evaluated serum C reactive protein, (CRP) pre-albumin (PA) and transferrin (TR) levels in AE-COPD patients requiring MV as prognostic markers of in hospital mortality. 93 AE-COPD patients on MV were evaluated. Detailed clinical evaluation was done daily. Serum CRP & PA were measured on admission, 3rd, 8th and 16th day; TR was measured on admission, 8th and 16th day. Demographics, baseline parameters, CRP, PA and TR were correlated with mortality. Of 93 patients, 49 (52.69%) survived whereas 44 patients (47.31%) died. APACHE II, serum urea & albumin were similar in survivors & non-survivors. Baseline CRP (≥10.5 mg/dl) had sensitivity of 60.5%, specificity of 60.2%, with area under curve (AUC) of 0.62 as predictor of mortality. CRP (≥7 mg/dl) on day 3 had sensitivity (65.5%) and specificity (63.3%) with AUC 0.70 as predictor of mortality. Baseline serum prealbumin was 11.00 (0.09-29.26) mg/dl, and similar in survivors & non-survivors (p = 0.7). Prealbumin at day 8 (n = 50) < 13.5 mg/dl had sensitivity 54.6%, and specificity 51.4% with AUC 0.54 (95% CI 0.34-0.75) as predictor of mortality. Transferrin at day 8 (n = 50) of <148.9 had sensitivity 63.4% and specificity 61.4% with AUC 0.61 with respect to mortality. High CRP levels at baseline, persistently elevated CRP (on day 3) may predict mortality in AE-COPD patients requiring MV. Further studies are required to establish prognostic variables in this patient population.

Entities:  

Keywords:  Acute phase reactants; COPD acute exacerbation; CRP; prognosis in AE COPD

Mesh:

Substances:

Year:  2019        PMID: 31820666     DOI: 10.1080/15412555.2019.1698019

Source DB:  PubMed          Journal:  COPD        ISSN: 1541-2563            Impact factor:   2.409


  3 in total

1.  Inhaled high molecular weight hyaluronan ameliorates respiratory failure in acute COPD exacerbation: a pilot study.

Authors:  Raffaele A Incalzi; Stavros Garantziotis; Flavia Galdi; Claudio Pedone; Christopher A McGee; Margaret George; Annette B Rice; Shah S Hussain; Kadambari Vijaykumar; Evan R Boitet; Guillermo J Tearney; John A McGrath; Audrey R Brown; Steven M Rowe
Journal:  Respir Res       Date:  2021-02-01

2.  Serum Creatinine/Cystatin C Ratio as a Predictor of In-hospital Mortality in Patients Hospitalized with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

Authors:  Zhixiang Chen; Lei Zha; Xiao Ma; Jing Xu; Dandan Huang; Wenlong Wu; Long Chen; Feng Yang; Weiling Liao; Wenhua Wang
Journal:  Lung       Date:  2022-09-15       Impact factor: 3.777

3.  Comparison of Immediate and Sequential Withdrawal of a Systemic Glucocorticoid in the Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Multicenter, Randomized, Double-Blind, Parallel-Controlled, Open-Label Study.

Authors:  Ling Zhou; Yuanyuan Fang; Wei Liu; Jianchu Zhang; Yingnan Wang; Sheng Xie; Minhua Zhong; Zhengyan Wang; Guangcai Li; Hongyan Ai; Hongrong Guo; Fanjun Zeng; Wei Xiao; Chenghong Li; Yi Hu; Yijun Tang; Huiguo Liu
Journal:  Front Mol Biosci       Date:  2021-05-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.